Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. 2003

Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
Department of Physiology, College of Medicine, Kyung Hee University, Seoul, Korea.

To investigate whether bee venom (BV) induces apoptosis, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, terminal deoxynucleotidyl transferase- mediated dUTP nick end-labeling assay, 4,6-diamidino-2-phenylindole staining, flow cytometric analysis, and DNA fragmentation assay were performed on NCI-H1299 lung cancer cells treated with BV. Through morphological and biochemical analyses, it was demonstrated that NCI-H1299 cells treated with BV exhibit several features of apoptosis. In addition, reverse transcription-polymerase chain reaction and prostaglandin E(2) (PGE(2)) immunoassay were performed to verify whether BV possesses an inhibitory effect on the expression of cyclooxygenase (COX) and PGE(2 )synthesis. Expression of COX-2 mRNA and synthesis of PGE(2) were inhibited by BV. These results suggest the possibility that BV may exert an anti-tumor effect on human lung cancer.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell

Related Publications

Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
April 2017, Molecular medicine reports,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
January 2020, Journal of Cancer,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
June 2020, Oncology reports,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
February 2016, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
February 2014, Molecular medicine reports,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
December 2020, Molecular medicine reports,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
January 2000, Anticancer research,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
September 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
March 2012, Cancer biotherapy & radiopharmaceuticals,
Mi-Hyeon Jang, and Min-Chul Shin, and Sabina Lim, and Seung-Moo Han, and Hi-Joon Park, and Insop Shin, and Ji-Suk Lee, and Kyoung-Ah Kim, and Ee-Hwa Kim, and Chang-Ju Kim
April 2015, Genetics and molecular research : GMR,
Copied contents to your clipboard!